EUVIMEDEUVIMED entdecken
Crossref

Analysis of antibiotic resistance and risk factors of extended-spectrum beta-lactamases-producing Escherichia coli in hospitalized children with community-acquired urinary tract infections

Yuan Lin, Qin Peng, Wangqiang Li, Biquan Chen

International Urology and Nephrology · 13.02.2025 · 57 (7) · 2271-2278

DOI: 10.1007/s11255-025-04417-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Urology and Nephrology, online erschienen am 13.02.2025. Verfasst von Yuan Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Anhui Provincial Children's Hospital, HeFei, 230001, China. Hauptthemen laut MEDLINE: Urinary Tract Infections, beta-Lactamases, Escherichia coli, Escherichia coli Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The incidence of extended-spectrum beta-lactamases (ESBLs)-producing Escherichia coli (E. coli) infections is rising. This study investigates the antibiotic resistance profiles and risk factors associated with ESBL-producing E. coli in urinary tract infections (UTIs) among hospitalized children, providing a basis for rational clinical management. METHODS: We analyzed the clinical data of 140 children diagnosed with UTIs caused by E. coli at Anhui Provincial Children's Hospital from July 2021 and June 2024 in this retrospective study. RESULTS: Among the 140 E. coli strains isolated, the male-to-female ratio was 1.75:1, with a median age of 7 months. Seventy-five strains (53.6%) were identified as ESBL producers. Non-ESBL-producing strains exhibited the highest resistance to ampicillin (60%) and lower resistance rates to cephalosporins and monobactams. Resistance rates for ampicillin-sulbactam, piperacillin-tazobactam, and cefoperazone-sulbactam were 29.2%, 6.2%, and 6.2%, respectively. No resistance to nitrofurantoin was observed, and only two strains were resistant to carbapenems. ESBL-producing strains demonstrated significantly higher resistance rates to most clinically relevant antimicrobials compared to non-producing strains. Among cephalosporins, resistance rates exceeded 90% for cefazolin, cefuroxime, and ceftriaxone, followed by cefepime (65.3%) and ceftazidime (29.3%). Notably, resistance to ampicillin-sulbactam was 50.7%, with greater sensitivity observed for cefoperazone-sulbactam and piperacillin-tazobactam. Resistance to cefotetan and nitrofurantoin remained low, and no carbapenem-resistant ESBL-producing strains were identified. Multifactorial logistic regression analysis indicated that abnormal urinary tract structure and a history of antibiotic treatment within the past 3 months were independent risk factors for UTIs caused by ESBL-producing E. coli (OR = 2.323, 95% CI = 1.052-5.129, P = 0.037 and OR = 3.378, 95% CI = 1.116-10.224, P = 0.031, respectively). CONCLUSIONS: ESBL-producing E. coli infections in pediatric UTIs are very common in our hospital, with high resistance rates to many used antibiotics. Awareness of the risk factors-namely, abnormal urinary tract structure and recent antibiotic treatment-is essential for effective management. Empirical treatment should involve a rational selection of antimicrobials based on local bacterial resistance patterns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Tract Infectionsbeta-LactamasesEscherichia coliEscherichia coli InfectionsDrug Resistance, BacterialHumansMaleFemaleRetrospective StudiesRisk FactorsInfantCommunity-Acquired InfectionsChild, PreschoolChildAnti-Bacterial AgentsHospitalizationChild, Hospitalized

Stichwörter der Autor:innen

Escherichia coliAntibiotic resistanceExtended-spectrum beta-lactamasesUrinary tract infection

Substanzen

beta-LactamasesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Anhui Provincial Children's Hospital, HeFei, 230001, China.
  • Department of Infectious Diseases, Anhui Provincial Children's Hospital, HeFei, 230001, China. Defin0918@outlook.com.

Zitieren

APA

Lin, Y., Peng, Q., Li, W., & Chen, B. (2025). Analysis of antibiotic resistance and risk factors of extended-spectrum beta-lactamases-producing Escherichia coli in hospitalized children with community-acquired urinary tract infections. International Urology and Nephrology, 57(7), 2271-2278. https://doi.org/10.1007/s11255-025-04417-1

Vancouver

Lin Y, Peng Q, Li W, Chen B. Analysis of antibiotic resistance and risk factors of extended-spectrum beta-lactamases-producing Escherichia coli in hospitalized children with community-acquired urinary tract infections. International Urology and Nephrology. 2025;57(7):2271-2278. doi:10.1007/s11255-025-04417-1

BibTeX
@article{Lin2025,
  author = {Lin, Yuan and Peng, Qin and Li, Wangqiang and Chen, Biquan},
  title = {Analysis of antibiotic resistance and risk factors of extended-spectrum beta-lactamases-producing Escherichia coli in hospitalized children with community-acquired urinary tract infections},
  journal = {International Urology and Nephrology},
  year = {2025},
  volume = {57},
  number = {7},
  pages = {2271--2278},
  doi = {10.1007/s11255-025-04417-1}
}
Kostenlos starten →